Concepedia

Author

Dirk Strumberg

Universitätsklinik Marien Hospital HerneORCID

Also Known As

D Strumberg, D. Strumberg, Dirk Strumberg, J Zieren, J.-U. Deuker, L. Claeys, Strumberg, D.

241

Publications

9.6K

Citations

48

H-Index

74

Concepts

All Affiliations

Universitätsklinik Marien Hospital HerneRuhr University BochumBayer (Germany)University of Duisburg-EssenWest German Heart and Vascular Center Essen
DS

About

Dirk Strumberg is an author at Universitätsklinik Marien Hospital Herne specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

47

2.8K

2

Health Sciences

6

6

148

3

Natural Sciences

2

2

176

4

Biochemistry

2

2

176

5

Engineering

1

1

135

Dirk Strumberg

×

82

Publications

7.3K

Citations

42

H-Index

YearCitations

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

Dirk Strumberg, Heike Richly, Ralf A. Hilger,

Journal of Clinical Oncology

2004

870

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial

Michael Untch, Sibylle Loibl, Joachim Bischoff,

The Lancet Oncology

2012

453

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy

Reinhold Kerb, Thomas E. Mürdter, Urs Giger-Pabst,

Annals of Surgical Oncology

2013

364

Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff

Dirk Strumberg, André A. Pilon, Melanie Smith,

Molecular and Cellular Biology

2000

354

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours

Ahmad Awada, Alain Hendlisz, Thierry Gil,

British Journal of Cancer

2005

338

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

Dirk Strumberg, M. E. Scheulen, Beate Schultheis,

British Journal of Cancer

2012

252

First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors

Beate Schultheis, Dirk Strumberg, Ansgar Santel,

Journal of Clinical Oncology

2014

250

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer

Dirk Strumberg, Simone van der Sar–van der Brugge, Michael W. Korn,

Annals of Oncology

2002

233

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis

Giorgi Nadiradze, Urs Giger-Pabst, Juergen Zieren,

Journal of Gastrointestinal Surgery

2015

200

Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening

C.C.P. Verstappen, Susanne Koeppen, J.J. Heimans,

Neurology

2005

196

Page 1